Oren Isacoff - Net Worth and Insider Trading

Oren Isacoff Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Oren Isacoff owns 1 companies in total, including Checkmate Pharmaceuticals Inc (CMPI) .

Click here to see the complete history of Oren Isacoff’s form 4 insider trades.

Insider Ownership Summary of Oren Isacoff

Ticker Comapny Transaction Date Type of Owner
CMPI Checkmate Pharmaceuticals Inc 2020-08-06 director

Oren Isacoff Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Oren Isacoff Ownership Network

Ownership Network List of Oren Isacoff

No Data

Ownership Network Relation of Oren Isacoff

Insider Network Chart

Oren Isacoff Owned Company Details

What does Checkmate Pharmaceuticals Inc do?

Who are the key executives at Checkmate Pharmaceuticals Inc?

Oren Isacoff is the director of Checkmate Pharmaceuticals Inc. Other key executives at Checkmate Pharmaceuticals Inc include 10 percent owner Venbio Global Strategic Fund Ii L.p. , director & Chief Executive Officer Alan Bash , and 10 percent owner Novo Holdings A/s .

Checkmate Pharmaceuticals Inc (CMPI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Checkmate Pharmaceuticals Inc (CMPI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Checkmate Pharmaceuticals Inc (CMPI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Checkmate Pharmaceuticals Inc (CMPI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Checkmate Pharmaceuticals Inc Insider Transactions

No Available Data

Oren Isacoff Mailing Address

Above is the net worth, insider trading, and ownership report for Oren Isacoff. You might contact Oren Isacoff via mailing address: C/o Longitude Capital 2740 Sand Hill Road, 2nd Floor Menlo Park Ca 94025.

Discussions on Oren Isacoff

No discussions yet.